Computer-aided detection developer iCAD has received Food and Drug Administration clearance for a new version of its MammoReader software. The new release improves the software's detection rates for calcifications and masses, yielding an overall sensitivity of 90.5%, according to the Nashua, NH-based firm.
In addition, iCAD said that the new version reduces the total number of suspicious areas in a mammogram by as much as 12.6%, with the marker rate for calcifications cut by up to 25%. The company believes this improved discrimination will improve the utility of the software for radiologists.
By AuntMinnie.com staff writersMarch 5, 2003
Related Reading
iCAD, Scanis ink licensing, supply deals, February 24, 2003
iCAD moves office, January 24, 2003
iCAD partners with two digital mammography vendors, December 4, 2002
iCAD introduces new MammoReader version, November 1, 2002
Mammography screening controversy doesn’t dampen vendor efforts, Part II, November 18, 2002
Copyright © 2003 AuntMinnie.com
